NALTREXONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF OPIOID DEPENDENCE

被引：242

作者：

GONZALEZ, JP ^{[1
]}

BROGDEN, RN ^{[1
]}

机构：

[1] ADIS DRUG INFORMAT SERV,AUCKLAND,NEW ZEALAND

来源：

关键词：

D O I：

10.2165/00003495-198835030-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：192 / 213

页数：22

共 108 条

[81] RESNICK RB, 1974, AM J PSYCHIAT, V131, P646
[82] RESNICK RB, 1980, NIDA RES MONOGR, V34, P109
[83] ROSENKRANTZ H, 1984, J CLIN PSYCHIATRY, V49, P11
[84] ROTH RH, 1982, J CLIN PSYCHIAT, V43, P42
[85] MINIREVIEW ON THE SPECIFICITY OF NALOXONE AS AN OPIATE ANTAGONIST
SAWYNOK, J
PINSKY, C
LABELLA, FS
[J]. LIFE SCIENCES, 1979, 25 (19) : 1621 - 1631
[86] NALTREXONE AND ALZHEIMERS-DISEASE
SERBY, M
RESNICK, R
JORDAN, B
ADLER, J
CORWIN, J
ROTROSEN, JP
[J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1986, 10 (3-5) : 587 - 590
[87] CRAVING IN HEROIN-ADDICTS MAINTAINED ON THE OPIATE ANTAGONIST NALTREXONE
SIDEROFF, SI
CHARUVASTRA, VC
JARVIK, ME
OUREN, J
[J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1978, 5 (04) : 415 - 423
[88] SIMPSON GM, 1977, CURR THER RES CLIN E, V22, P909
[89] TAYLOR SM, 1980, J PHARMACOL EXP THER, V213, P289
[90] SUPER-SENSITIVITY OF BRAIN OPIATE RECEPTOR SUBTYPES AFTER CHRONIC NALTREXONE TREATMENT
TEMPEL, A
ZUKIN, RS
GARDNER, EL
[J]. LIFE SCIENCES, 1982, 31 (12-1) : 1401 - 1404